Type I and Type III Interferons - Induction, Signaling, Evasion, and Application to Combat COVID-19

Area of Science:

• Immunology
• Virology
• Infectious Diseases

Background:

• COVID-19, caused by SARS-CoV-2, is a global pandemic lacking specific antiviral treatments.
• Interferons (IFNs) are crucial for innate antiviral responses.
• Previous studies on related coronaviruses (SARS-CoV, MERS-CoV) showed controversial results regarding IFN efficacy.

Purpose of the Study:

• To review current understanding of type I and type III IFN-mediated antiviral responses against human coronaviruses.
• To discuss the potential of IFNs as a therapeutic strategy for COVID-19.

Main Methods:

• Literature review of recent research on interferons and coronaviruses.
• Analysis of innate antiviral mechanisms involving type I and type III IFNs.
• Evaluation of existing data on IFN use in SARS-CoV and MERS-CoV infections.

Main Results:

• Type I and type III IFNs play significant roles in controlling viral replication in human coronavirus infections.
• The specific roles and optimal use of IFNs in coronavirus infections are still under investigation.
• Recombinant IFNs have shown potential but also raise concerns based on prior coronavirus studies.

Conclusions:

• Understanding IFN-mediated immunity is critical for developing effective COVID-19 treatments.
• Interferon-based therapies warrant further investigation for COVID-19, considering both benefits and potential drawbacks.
• Targeting IFN pathways could be a promising strategy against SARS-CoV-2 and other human coronaviruses.